Genetic Technologies Ltd (GTG)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Genetic Technologies Ltd (GTG) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013851
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genetic Technologies Ltd (GTG) is a genetic tests company that offers testing products and services to assess sporadic breast cancer risk and cancer development, progression and management. It delivers the offerings by BREVAGen and BREVAGenplus tests. BREVAGen test enables the customers to assess breast cancer screening and make preventive treatment plans; BREVAGenplus test examines woman’s clinical risk factors with scientifically validated genetic bio markers, to enable personalized breast cancer risk assessment and risk management. The tests are clinically validated on African, American, Caucasian and Hispanic women. The company serves test providers and patients in the US and Australia. GTG is headquartered in Fitzroy, Victoria, Australia.

Genetic Technologies Ltd (GTG) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genetic Technologies Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Genetic Technologies Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Genetic Technologies Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Genetic Technologies Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Genetic Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Genetic Technologies Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Genetic Technologies Enters into Licensing Agreement with University of Melbourne 10
Genetic Technologies Enters Into Co-Development Agreement With A Global Pharma Company 11
Genetic Technologies Enters Into Licensing Agreement With Bio-Reference Labs 12
Equity Offering 13
Genetic Technologies to Raise USD6 Million in Private Placement of ADS 13
Genetic Technologies Raises USD14.5 Million in Private Placement of Shares 14
Genetic Technologies to Raise USD20 Million in Private Placement of Shares 15
Genetic Technologies Raises USD0.2 Million in Private Placement Of Shares 16
Genetic Technologies Completes Second Tranche Of Rights Offering Of Shares For US$1.3 Million 17
Genetic Technologies Completes Private Placement Of Shares For US$2.7 Million 18
Genetic Technologies Announces Public Offering Of Shares 19
Genetic Technologies Completes Private Placement Of Shares For US$12.6 Million 20
Debt Offering 21
Genetic Technologies Completes Private Placement Of Notes For US$5 Million 21
Genetic Technologies Ltd – Key Competitors 22
Genetic Technologies Ltd – Key Employees 23
Genetic Technologies Ltd – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Jul 27, 2017: Genetic Technologies: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 June 2017 25
Legal and Regulatory 28
Feb 05, 2016: Genetic Technologies Executes Settlement and Release Agreement With Hendrix Genetics 28
Product News 29
02/22/2016: Genetic Technologies and IndyCar’s Pippa Mann Announce Partnership to Promote BREVAGenplus 29
Other Significant Developments 30
Oct 30, 2017: Genetic Technologies Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 September 2017 30
Aug 25, 2017: Genetic Technologies Announces Comprehensive Review of Strategic Alternatives 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Genetic Technologies Ltd, Medical Equipment, Key Facts, 2017 2
Genetic Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Genetic Technologies Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Genetic Technologies Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Genetic Technologies Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Genetic Technologies Ltd, Deals By Market, 2011 to YTD 2017 8
Genetic Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Genetic Technologies Enters into Licensing Agreement with University of Melbourne 10
Genetic Technologies Enters Into Co-Development Agreement With A Global Pharma Company 11
Genetic Technologies Enters Into Licensing Agreement With Bio-Reference Labs 12
Genetic Technologies to Raise USD6 Million in Private Placement of ADS 13
Genetic Technologies Raises USD14.5 Million in Private Placement of Shares 14
Genetic Technologies to Raise USD20 Million in Private Placement of Shares 15
Genetic Technologies Raises USD0.2 Million in Private Placement Of Shares 16
Genetic Technologies Completes Second Tranche Of Rights Offering Of Shares For US$1.3 Million 17
Genetic Technologies Completes Private Placement Of Shares For US$2.7 Million 18
Genetic Technologies Announces Public Offering Of Shares 19
Genetic Technologies Completes Private Placement Of Shares For US$12.6 Million 20
Genetic Technologies Completes Private Placement Of Notes For US$5 Million 21
Genetic Technologies Ltd, Key Competitors 22
Genetic Technologies Ltd, Key Employees 23
Genetic Technologies Ltd, Subsidiaries 24

★海外企業調査レポート[Genetic Technologies Ltd (GTG)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Al Hassan Engineering Co (HECI):企業の財務・戦略的SWOT分析
    Al Hassan Engineering Co (HECI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Recepta Biopharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Recepta Biopharma SA (Recepta) is a biotechnology company that offers research and development of drugs used in the treatment of cancer. The company offers antibodies and peptide products. It offers antibodies such as monoclonal antibody hu3s193 - anti-ley, monoclonal antibody 58-1066 - anti …
  • Nick Scali Ltd (NCK):企業の財務・戦略的SWOT分析
    Nick Scali Ltd (NCK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Information Services International-Dentsu Ltd (4812):企業の財務・戦略的SWOT分析
    Information Services International-Dentsu Ltd (4812) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Epinex Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Epinex Diagnostics Inc (Epinex) is a medical device company that offers rapid diagnostic tests. The company’s products comprise point-of-care test device and over-the-counter test device. Its Epinex G1A system is rapid diabetes monitoring index test for the control of glycation. Epinex offer …
  • Tompkins Financial Corp (TMP):企業の財務・戦略的SWOT分析
    Tompkins Financial Corp (TMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Nordson Corporation:企業の戦略・SWOT・財務情報
    Nordson Corporation - Strategy, SWOT and Corporate Finance Report Summary Nordson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sun Pharmaceutical Industries Ltd (SUNPHARMA):医療機器:M&Aディール及び事業提携情報
    Summary Sun Pharmaceutical Industries Ltd (Sun Pharma) is a specialty pharmaceutical company, which offers a wide range of pharmaceutical formulations such as branded generics and generic pharmaceuticals. The company’s products find application in the treatment of various conditions related to psych …
  • Bonavista Energy Corp (BNP):企業の財務・戦略的SWOT分析
    Bonavista Energy Corp (BNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • New Silkroad Culturaltainment Limited.:企業の戦略・SWOT・財務分析
    New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report Summary New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Celanese Corp (CE):企業の財務・戦略的SWOT分析
    Celanese Corp (CE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Westfalen Weser Netz GmbH:企業の戦略的SWOT分析
    Westfalen Weser Netz GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • ADM Tronics Unlimited Inc (ADMT):企業の財務・戦略的SWOT分析
    ADM Tronics Unlimited Inc (ADMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Banco Hipotecario SA (BHIP3):企業の財務・戦略的SWOT分析
    Banco Hipotecario SA (BHIP3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Cardinal Ethanol LLC:企業の戦略的SWOT分析
    Cardinal Ethanol LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Ratchaburi Electricity Generating Holding Public Co Ltd (RATCH):電力:M&Aディール及び事業提携情報
    Summary Ratchaburi Electricity Generating Holding Public Company Limited (RATCH) is an independent power producer. Through investments in subsidiaries, associates and joint ventures, the company operates electricity generating and related businesses. It operates independent power producing and small …
  • East Japan Railway Company:企業の戦略・SWOT・財務情報
    East Japan Railway Company - Strategy, SWOT and Corporate Finance Report Summary East Japan Railway Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Methanol Chemicals Co (2001):企業の財務・戦略的SWOT分析
    Methanol Chemicals Co (2001) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Lietuvos energijos gamyba, AB (LNR1L)-エネルギー分野:企業M&A・提携分析
    Summary Lietuvos energijos gamyba, AB (Lietuvos), a subsidiary of Lietuvos Energija UAB, is a state-controlled electric utility that generates, imports and exports, and supplies electricity and thermal energy. It generates electricity from hydro, thermal and renewable energy sources. The company tra …
  • Qualcomm Incorporated (QCOM):企業の財務・戦略的SWOT分析
    Qualcomm Incorporated (QCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆